Rifamycin O as a Novel CRBN Ligand for Targeted Degradation of IKZF1/3 Proteins in Hematopoietic Malignancies

ABSTRACT: We found that Rifamycin O could effectively suppressed the hematologic tumors growth in vitro and in vivo. The antitumor effect of Rifamycin O is first identified so far.

ORGANISM(S): Homo sapiens

PROVIDER: GSE297439 | GEO | 2026/05/01

REPOSITORIES: GEO